Adolescents prefer long-acting injectables to daily oral HIV treatment, study finds
Top 5 stories on injectable HIV treatment and PrEP from CROI 2024
Top 5 stories on HIV and women from CROI 2024
Long-acting injectables can be a good option for people with adherence challenges
Top 5 stories on co-morbidities affecting people with HIV from CROI 2024
Should event-driven PrEP be an option for women?
Top 5 HIV treatment stories from CROI 2024
Semaglutide improves fatty liver disease and inflammation in people with HIV
The cornerstone of HIV treatment may be losing some of its power: will dolutegravir resistance become a problem?
